Caris Life Sciences, Inc.
CAI
Rangering i aksjer
#2194
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Aksjekurs
$32.28
Sist synkronisert: 2026-10-21
Markedsverdi
$9.12B
Endring (1 dag)
3.76%
Endring (1 år)
7.46%
Land
US
Handel Caris Life Sciences, Inc. (CAI)
Kategori
Healthcare
Historikk for aksjesplitt for Caris Life Sciences, Inc. (CAI)
Aksjen Caris Life Sciences, Inc. (symbol: CAI) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én CAI-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 CAI-aksjer.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én CAI-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 CAI-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
